Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astrazeneca, Atyr, CTI Biopharma, Daiichi Sankyo, Hua Medicine, Immutep, Regeneron, Romark, Sanofi, Theravance.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Archerdx, Thrive Earlier Detection.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Bioxcel, Blueprint, Genentech, Generex, I-Mab, Innate, Innovent, Inovio, Morphosys, Ocular, Orchard, R-Pharm, Rafael, Spectrum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sightglass Vision.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Avadel, Axsome, CTI Biopharma, Harpoon, Hua, Italfarmaco, Myovant, Regeneron, Sanofi, Valo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cagent Vascular.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bellicum, Boehringer, Chugai, GSK, Janssen, Kiromic, Merck, Novartis, Novocure, Noxxon, Sanofi, TC Biopharma, Tonix, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adocia, Aivita, Amryt, Astrazeneca, Baudax, Cel-Sci, Incyte, Leap, Obseva, Sanofi, Surface, Theravance, United Therapeutics, Windmil.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actelion, Astrazeneca, Bluebird, Boehringer, Exelixis, GSK, Harbour, Imbrium, Immutep, Incyte, Intra-Cellular, Kiniksa, Levo, Lilly, Prothena, Neoimmunetech, Regeneron, Regenxbio, Roche, Saniona, Sojournix, Tersera, UCB, United Therapeutics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied Therapeutics, Arcutis, Atyr, Cara, Catalyst, CSL Behring, Erytech, Hookipa, Idera, Novartis, Oncoimmune, Synexis.